Replies to post #100133 on Biotech Values

[DewDiligence]

The article in #msg-52553991 is on-point, especially the third paragraph. Regards, Dew

p.s. The article was written on July 22, the day before Teva’s share price suffered a 10% hit. Bad timing by Merrill Lynch :- )